These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 8773291

  • 1. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
    Möller HJ, Kasper S, Müller H, Kissling W, Fuger J, Ruhrmann S.
    Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
    [Abstract] [Full Text] [Related]

  • 2. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD.
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [Abstract] [Full Text] [Related]

  • 3. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J, Barkin RL.
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [Abstract] [Full Text] [Related]

  • 4. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT, Glaudin V, Panagides J, Gilvary E.
    Psychopharmacol Bull; 1990 Mar; 26(2):191-6. PubMed ID: 2236455
    [Abstract] [Full Text] [Related]

  • 5. A double blind comparative study of mianserin and a fixed combination of amitriptyline plus chlordiazepoxide.
    Dimitriou EC, Logothetis JA, Paschalidou M.
    Adv Biochem Psychopharmacol; 1982 Mar; 32():213-22. PubMed ID: 7046365
    [Abstract] [Full Text] [Related]

  • 6. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J, Ryde L, Svejsø J, Lauge N, Lauritsen B, Bech P.
    Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
    Altintoprak AE, Zorlu N, Coskunol H, Akdeniz F, Kitapcioglu G.
    Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
    [Abstract] [Full Text] [Related]

  • 8. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
    Marchesi C, Ceccherininelli A, Rossi A, Maggini C.
    Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
    [Abstract] [Full Text] [Related]

  • 9. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
    Möslinger-Gehmayr R, Zaninelli R, Contu A, Oberhoff C, Gutschow K, Schindler AE, Staab HJ.
    Zentralbl Gynakol; 2000 Nov; 122(4):195-202. PubMed ID: 10795116
    [Abstract] [Full Text] [Related]

  • 10. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients.
    Möller HJ, Berzewski H, Eckmann F, Gonzalves N, Kissling W, Knorr W, Ressler P, Rudolf GA, Steinmeyer EM, Magyar I.
    Pharmacopsychiatry; 1993 May; 26(3):75-8. PubMed ID: 8415897
    [Abstract] [Full Text] [Related]

  • 11. Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression.
    Stahl S, Zivkov M, Reimitz PE, Panagides J, Hoff W.
    Acta Psychiatr Scand Suppl; 1997 May; 391():22-30. PubMed ID: 9265948
    [Abstract] [Full Text] [Related]

  • 12. A controlled study of mianserin in moderately to severely depressed outpatients.
    Carman JS, Ahdieh H, Wyatt-Knowles E, Warga E, Panagides J.
    Psychopharmacol Bull; 1991 May; 27(2):135-9. PubMed ID: 1924659
    [Abstract] [Full Text] [Related]

  • 13. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A, Fouilloux C, Ortiz S.
    Proc West Pharmacol Soc; 2002 May; 45():154-5. PubMed ID: 12434564
    [No Abstract] [Full Text] [Related]

  • 14. Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome.
    Rao ML, Ruhrmann S, Retey B, Liappis N, Fuger J, Kraemer M, Kasper S, Möller HJ.
    Pharmacopsychiatry; 1996 Sep; 29(5):180-6. PubMed ID: 8895943
    [Abstract] [Full Text] [Related]

  • 15. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
    van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J.
    Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
    [Abstract] [Full Text] [Related]

  • 16. Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients.
    Monteleone P, Fabrazzo M.
    Pharmacopsychiatry; 1994 Nov; 27(6):238-41. PubMed ID: 7870745
    [Abstract] [Full Text] [Related]

  • 17. Mianserin and maprotiline as compared to amitriptyline in severe endogenous depression. A new methodological approach to the clinical evaluation of the efficacy of antidepressants.
    Cording-Tömmel C, von Zerssen D.
    Pharmacopsychiatria; 1982 Nov; 15(6):197-204. PubMed ID: 7156183
    [Abstract] [Full Text] [Related]

  • 18. [The comparative studies of therapeutic results in patients with psychotic refractory depression treated with selected antidepressants and unilateral ECT].
    Hese RT, Gruszczyński W, Szwed A, Kielc M, Zalitacz M.
    Psychiatr Pol; 2002 Nov; 36(6 Suppl):81-4. PubMed ID: 12647425
    [Abstract] [Full Text] [Related]

  • 19. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT.
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.